Merck application for two drug regimen for adults with virologically suppressed HIV 1 infection under USFDA review Ruchika Sharma11 July 2025 12:19 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has...
New credit card-sized TB test could close the diagnostic gap in HIV hotspots: Study Dr. Kamal Kant Kohli9 July 2025 7:15 AM ISTCurrent tuberculosis infection tests struggle to detect the disease in those with HIV. A common co-infection, HIV can hide TB from traditional tests...
Laurus Labs Asked to Submit Justification, Data for Pediatric Darunavir-Ritonavir FDC Proposal Farhat Nasim23 Jun 2025 3:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) on Antimicrobial & Antiviral under the Central Drugs Standard Control Organisation (CDSCO) has asked...
Kozhikode Medical College's HIV Testing Laboratory Receives NABL Accreditation Kajal Rajput22 Jun 2025 12:30 PM ISTKozhikode: The HIV Testing Laboratory under the Microbiology Department of Kozhikode Medical College, managed by the Kerala AIDS Control Society,...
Mizoram Health Minister calls for urgent action as State leads in HIV cases Kajal Rajput22 Jun 2025 11:00 AM ISTAizawl: Mizoram Health Minister Lalrinpuii has called for urgent and coordinated efforts to address the state's HIV crisis, as Mizoram continues...
FDA Approves First Twice-Yearly Injectable PrEP for HIV Prevention Dr. Kamal Kant Kohli19 Jun 2025 9:00 PM ISTThe US Food and Drug Administration has approved lenacapavir (Yeztugo), the first twice-yearly injectable HIV-1 prevention option. As a capsid...
Gilead Sciences twice-yearly injection for HIV prevention bags USFDA okay Ruchika Sharma19 Jun 2025 11:56 AM ISTFoster City: Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for...
USFDA places clinical hold on Gilead Sciences trials testing HIV pill combination Ruchika Sharma11 Jun 2025 12:13 PM ISTFoster City: Gilead Sciences has announced that the U.S. Food and Drug Administration has placed a clinical hold on its HIV treatment trials...
Medical Bulletin 9/June/2025 Dr. Bhumika Maikhuri9 Jun 2025 9:00 AM ISTHere are the top medical bulletins for the day:Trial Shows Low Cost Antibiotic Use May Reduce Preterm Births in Women with HIVA new study published in...
Trial Shows Low Cost Antibiotic Use May Reduce Preterm Births in Women with HIV Dr. Bhumika Maikhuri9 Jun 2025 8:00 AM ISTA new study published in the New England Journal of Medicine has found that a commonly used, low-cost antibiotic may significantly reduce the risk of...
HHS panel recommend statins for adults with HIV at risk for cardiovascular disease Dr. Kamal Kant Kohli8 Jun 2025 9:00 PM ISTIn February 2024, the U.S. Department of Health and Human Services Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (ARV...
HIV drug kickbacks: Gilead Sciences to pay USD 202 million to settle lawsuit Ruchika Sharma1 May 2025 3:15 PM ISTNew York: Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in civil fraud...
